A functional SNP in the promoter region of TCOF1 is associated with reduced gene expression and YY1 DNA-protein interaction.
Treacher Collins syndrome (TCS) is an autosomal dominant craniofacial malformation caused by null mutations in the TCOF1 gene. High inter and intra familial clinical variability, ranging from mild malar hypoplasia to perinatal death due to airway collapse is observed, but, to date, no genotype-phenotype correlation has been reported. Considering haploinsufficiency as the molecular mechanism underlying the disease, we have hypothesized that mutations in the promoter region of the gene, which has never been previously characterized, in trans with a pathogenic mutation, could modulate the phenotype. Therefore, the aims of the present study were to determine the TCOF1 gene's core promoter and to identify mutations in this region that could contribute to the phenotypic variation observed in this syndrome. We have delimitated the minimal promoter to a region of less than 150 bp, with 63% of identity among 5 different species. We screened 1.2 kbp of the TCOF1 5' flanking sequence in the DNA obtained from 21 patients and 51 controls and identified four new single nucleotide polymorphisms (SNPs), one of which (-346C>T), was proved to be functional, as it decreased the promoter activity by 38%. Electrophoretic mobility shift assay (EMSA) analysis demonstrated that the -346T allele impairs DNA-binding to the YY1 transcription factor. This promoter variant represents a candidate allele to explain the clinical variability in patients bearing TCS.
Masotti
Cibele
C
Instituto de Biociências, Universidade de São Paulo, Departamento de Biologia, Rua do Matão, 277/Sala 200, 05508-900 São Paulo/SP, Brazil.
Armelin-Correa
Lucia M
LM
Splendore
Alessandra
A
Lin
Chin J
CJ
Barbosa
Angela
A
Sogayar
Mari C
MC
Passos-Bueno
Maria Rita
MR
D000483:Alleles; D000818:Animals; D001483:Base Sequence; D001667:Binding, Competitive; D001938:Brazil; D045744:Cell Line, Tumor; D004252:DNA Mutational Analysis; D004285:Dogs; D024202:Electrophoretic Mobility Shift Assay; D005192:Family Health; D005260:Female; D005786:Gene Expression Regulation; D005787:Gene Frequency; D005820:Genetic Testing; D005822:Genetic Vectors / Q000235:genetics; D006801:Humans; D008297:Male; D008342:Mandibulofacial Dysostosis / Q000175:diagnosis / Q000235:genetics; D051379:Mice; D008969:Molecular Sequence Data; D009154:Mutation; D009687:Nuclear Proteins / Q000235:genetics* / Q000378:metabolism; D002679:Pan troglodytes; D010375:Pedigree; D010750:Phosphoproteins / Q000235:genetics* / Q000378:metabolism; D020641:Polymorphism, Single Nucleotide; D011401:Promoter Regions, Genetic / Q000235:genetics*; D011485:Protein Binding / Q000235:genetics; D051381:Rats; D016415:Sequence Alignment; D012689:Sequence Homology, Nucleic Acid; D013045:Species Specificity; D014162:Transfection; D050986:YY1 Transcription Factor / Q000235:genetics / Q000378:metabolism*
D009687:Nuclear Proteins; D010750:Phosphoproteins; C105442:TCOF1 protein, human; D050986:YY1 Transcription Factor; C494698:YY1 protein, human